Source disclosure: February 18, 2026
Kubota Pharmaceutical Holdings Co., Ltd. [4596.T]
TOKYO, Feb 18 (Pulse News Wire) – Kubota Pharmaceutical Holdings CO.,LTD. (4596.T) announced today that its CEO, Yoshi Kubota, has withdrawn his annual salary due to recent sales declines.
At a board meeting held, the company accepted the resignation of the CEO's compensation for the fiscal year ending March 2026, amounting to ¥22.5 million. Additionally, he plans to forego his fixed monthly remuneration totaling ¥67.5 million for the remainder of the fiscal year, beginning April 2026 through December 2026. The total amount waived amounts to ¥90 million.
The decision reflects the CEO’s commitment to addressing ongoing sales challenges and demonstrates his dedication to future corporate reforms. Despite the limited impact on the current fiscal performance, the company views this move as a strategic investment towards enhancing revenue foundations and improving capital efficiency in the long term. Kubota Pharmaceutical remains committed to achieving its mission of eradicating nearsightedness globally and fulfilling shareholder expectations.
The company will continue to push forward with unified efforts across the organization.
AI-translated content. 🟢 Confidence: High See terms • Original filing